0000950170-24-071919.txt : 20240611 0000950170-24-071919.hdr.sgml : 20240611 20240611161809 ACCESSION NUMBER: 0000950170-24-071919 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hughes-Wilson Alexandra CENTRAL INDEX KEY: 0002005875 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38452 FILM NUMBER: 241036006 MAIL ADDRESS: STREET 1: C/O MEREO BIOPHARMA STREET 2: 1 CAVENDISH PLACE CITY: LONDON STATE: X0 ZIP: W1G 0QF ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mereo BioPharma Group plc CENTRAL INDEX KEY: 0001719714 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF BUSINESS PHONE: 4403330237300 MAIL ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF FORMER COMPANY: FORMER CONFORMED NAME: Mereo Biopharma Group plc DATE OF NAME CHANGE: 20171016 4/A 1 ownership.xml 4/A X0508 4/A 2024-05-22 2024-05-23 0001719714 Mereo BioPharma Group plc MREO 0002005875 Hughes-Wilson Alexandra C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM false true false false See Remarks false American Depositary Shares representing Ordinary Shares 7650 D Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. This Amended Form 4 amends the Form 4 filed by the Reporting Person on May 23, 2024 (the "Original Form 4"). The transactions reported in the Original Form 4 were canceled in their entirety prior to settlement and, as a result, no shares were transferred. Chief Patient Access and Commercial Planning /s/ Christine Fox, by power of attorney 2024-06-11